CTT Pharmaceutical reports six-month net loss
CTT Pharmaceutical Holdings reported a net loss for the six months ended June 30, 2026, versus a net loss in the year-ago six-month period. Diluted EPS remained $(0.00), and the company said it had no revenue-producing activities in the period.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.